Telix Pharmaceuticals | Evaluate

January 05, 2022

US FDA approval tracker: December 2021

November 30, 2021

Go or no go? Argenx's December showdown

2021 rounds off with key FDA decisions for Argenx, Calliditas and Merck, while Novartis will be hoping for an early Leqvio verdict.

October 01, 2021

US FDA approval tracker: September 2021

January 15, 2018

Tide turns as 2017 IPOs ramp up

Biotechs raised $3.9bn in IPOs across 2017, signalling that investor interest in new issues has returned.